Hydrochlorothiazide-induced acute non-cardiogenic pulmonary edema

P M Gamboa1, V Achotegui, J Irigoyen

  • 1Servicio de Alergología, Hospital de Basurto, Bilbao, Spain. pgamboa@hbas.osakidetza.net

Insights

Hydrochlorothiazide, a diuretic, can cause non-cardiogenic pulmonary edema. The exact cause remains unknown, suggesting an idiosyncratic drug reaction in susceptible individuals.

Area of Science:

  • Pharmacology
  • Immunology
  • Pulmonary Medicine

Background:

  • Hydrochlorothiazide is a commonly prescribed thiazide diuretic used to treat hypertension and edema.
  • Non-cardiogenic pulmonary edema is a rare but serious adverse effect associated with certain medications.

Observation:

  • A 64-year-old male experienced recurrent episodes of non-cardiogenic pulmonary edema following oral administration of hydrochlorothiazide (12.5 mg).
  • In vitro immunologic studies, including basophil activation and late cellular activation (CD69, interferon-gamma production) using chlorothiazide, showed no immune cell activation.

Findings:

  • The observed non-cardiogenic pulmonary edema in this case is likely an idiosyncratic reaction to hydrochlorothiazide.
  • The pathogenic mechanism underlying this adverse drug reaction remains undetermined, despite in vitro testing.

Implications:

  • This case highlights the potential for rare, idiosyncratic adverse reactions to commonly used diuretics like hydrochlorothiazide.
  • Further research is needed to elucidate the unknown mechanisms of diuretic-induced pulmonary edema to improve patient safety and management strategies.

Related Concept Videos

Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Pulmonary Edema II: Pathophysiology01:18

Pulmonary Edema II: Pathophysiology

Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...